Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

REVB

REVELATION BIOSCIENCES, INC.

CIK 0001810560 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.09
↑ 0.02 (1.87%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$4.26M
P/E Ratio
-0.40
EPS
-23.95
Dividend Yield
Not covered
52W Position
25%
Beta
1.36

Valuation multiples

Fwd P/E
0.89
PEG
Not covered
P/B
0.42
P/S
Not covered
EV/Revenue
Not covered
ROE
-106.8%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 25%
$0.47$2.93

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$8.91M
Total Assets
$11.58M
Free Cash Flow
–

Recent news